Archives of Toxicology

, Volume 81, Issue 7, pp 495–504 | Cite as

Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria

  • N. A. G. Santos
  • C. S. Catão
  • N. M. Martins
  • C. Curti
  • M. L. P. Bianchi
  • A. C. SantosEmail author
Organ Toxicity and Mechanisms


The clinical use of cisplatin (cis-diamminedichloroplatinum II) is highly limited by its nephrotoxicity. The precise mechanisms involved in cisplatin-induced mitochondrial dysfunction in kidney have not been completely clarified. Therefore, we investigated in vivo the effects of cisplatin on mitochondrial bioenergetics, redox state, and oxidative stress as well as the occurrence of cell death by apoptosis in cisplatin-treated rat kidney. Adult male Wistar rats weighing 200–220 g were divided into two groups. The control group (n = 8) was treated only with an intraperitoneal (i.p.) injection of saline solution (1 ml per 100 g body weight), and the cisplatin group (n = 8) was given a single injection of cisplatin (10 mg/kg body weight, i.p.). Animals were sacrificed 72 h after the treatment. The cisplatin group presented acute renal failure characterized by increased plasmatic creatinine and urea levels. Mitochondrial dysfunction was evidenced by the decline in membrane electrochemical potential and the substantial decrease in mitochondrial calcium uptake. The mitochondrial antioxidant defense system was depleted, as shown by decreased GSH and NADPH levels, GSH/GSSG ratio, and increased GSSG level. Moreover, cisplatin induced oxidative damage to mitochondrial lipids, including cardiolipin, and oxidation of mitocondrial proteins, as demonstrated by the significant decrease of sulfhydryl protein concentrations and increased levels of carbonylated proteins. Additionally, aconitase activity, which is essential for mitochondrial function, was also found to be lower in the cisplatin group. Renal cell death via apoptosis was evidenced by the increased caspase-3 activity. Results show the central role of mitochondria and the intensification of apoptosis in cisplatin-induced acute renal failure, highlighting a number of steps that might be targeted to minimize cisplatin-induced nephrotoxicity.


Cisplatin Mitochondria Nephrotoxicity Reactive oxygen species (ROS) 


  1. Antunes Greggi LM, Darin JD, Bianchi MD (2000) Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study. Pharmacol Res 41:405–411CrossRefGoogle Scholar
  2. Baek SM, Kwon CH, Kim JH, Jung JS, Kim YK (2003) Differencial roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med 142:178–186PubMedCrossRefGoogle Scholar
  3. Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV (1998) In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 53:394–401PubMedCrossRefGoogle Scholar
  4. Berry MN, Edwards AM, Barritt GJ (1991) High-yield preparation of isolated hepatocytes from rat liver. In: Burdon RH, Knippenberg PH (eds) Laboratory techniques in biochemistry and molecular biology. Isolated hepatocytes preparation, properties and applications. Elsevier, Amsterdam, pp 15–58Google Scholar
  5. Bowser DN, Petrou S, Panchal RG, Smart ML, Williams DA (2002) Release of mitochondrial Ca+2 via the permeability transition activates endoplasmic reticulum Ca+2 uptake. FASEB J 16:1105–1107PubMedGoogle Scholar
  6. Brady HR, Kone BC, Stromski ME, Zeidel ML, Giebisch G, Gullans SR (1990) Mitochondrial injury: an early event in cisplatin toxicity to renal proximal tubules. Am J Physiol (Renal Fluid Electrolyte Physiol) 258:F1181–F1187Google Scholar
  7. Cardoso SM, Pereira C, Oliveira R (1999) Mitochondrial function is differentially affected upon oxidative stress. Free Radic Biol Med 26:3–13PubMedCrossRefGoogle Scholar
  8. Chance B, Willians GR (1956) The respiratory chain and oxidative phosphorylation. Adv Enzymol 17:65–134Google Scholar
  9. Chang B, Nishikawa M, Sato E, Utsumi K, Inoue M (2002) L-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine. Arch Biochem Biophys 405:55–64PubMedCrossRefGoogle Scholar
  10. Conklin KA (2004) Cancer chemotherapy and antioxidants. J Nutr 134:3201S–3204SPubMedGoogle Scholar
  11. Cummings BS, Schnellmann RG (2002) Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. J Pharmacol Exp Ther 302:8–17PubMedCrossRefGoogle Scholar
  12. Cvitkovic E (1998) Cumulative toxicities from cisplatin therapy and current cytoprotective measures. Cancer Treat Rev 24:265–281PubMedCrossRefGoogle Scholar
  13. Emaus RK, Grunwald R, Lemasters JJ (1986) Rhodamine-123 as a probe of transmembrane potential in isolated rat-liver mitochondria-spectral and metabolic properties. Biochim Biophys Acta 850:436–448PubMedCrossRefGoogle Scholar
  14. Fariss MW, Chan CB, Patel M, Van Houten B, Orrenius S (2005) Role of mitochondria in toxic oxidative stress. Mol Interv 5:94–111PubMedCrossRefGoogle Scholar
  15. Gallet PF, Maftah A, Petit JM, Denis-Gay M, Julien R (1995) Direct cardiolipin assay In yeast using the red fluorescence emission of 10-N-nonyl acridine orange. Eur J Biochem 15:113–119CrossRefGoogle Scholar
  16. Grattagliano I, Vendemiale G, Sabbá C, Buonamico P, Altomare E (1996) Oxidation of circulating proteins in alcoholics: role of acetaldehyde and xantine oxidase. J Hepatol 25:28–36PubMedCrossRefGoogle Scholar
  17. Hanigan MH, Devarajan P (2003) Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther 1:47–61PubMedGoogle Scholar
  18. Hannemann J, Duwe J, Baumann K (1991) Iron and ascorbic acid-induced lipid peroxidation in renal microsomes isolated from rats treated with platinum compounds. Cancer Chemother Pharmacol 28:427–433PubMedCrossRefGoogle Scholar
  19. Hauff KD, Hatch GM (2006) Cardiolipin metabolism and Barth Syndrome. Prog Lipid Res 45:91–101PubMedCrossRefGoogle Scholar
  20. Hoffmann B, Stockl A, Schlame M, Beyer K, Klingenberg MJ (1994) The reconstituted ADP/ATP carrier activity has an absolute requirement for cardiolipin as shown in cysteine mutants. Biol Chem 269:1940–1944Google Scholar
  21. Huang H, Zhu L, Reid BR, Drobny GP, Hopkins PB (1995) Solution structure of a cisplatin-induced DNA interstrand cross-link. Science 270:1842–1845PubMedCrossRefGoogle Scholar
  22. Kadikoylu G, Bolaman Z, Demir S, Balkaya M, Akalin N, Enli Y (2004) The effects of desferrioxamine on cisplatin-induced lipid peroxidation and the activities of antioxidant enzymes in rat kidneys. Hum Exp Toxicol 23:29–34PubMedCrossRefGoogle Scholar
  23. Kagan VE, Tyurina YY, Bayir H, Chu CT, Kapralov AA, Vlasova II, Belikova NA, Tyurin VA, Amoscato A, Epperly M, Greenberger J, Dekosky S, Shvedova AA, Jiang J (2006) The “pro-apoptotic genies” get out of mitochondria: oxidative lipidomics and redox activity of cytochrome c/cardiolipin complexes. Chem Biol Interact 163:15–28PubMedCrossRefGoogle Scholar
  24. Kaushal GP, Kaushal V, Hong X, Shah SV (2001) Role and regulation of caspases in cisplatin induced injury to renal tubular epithelial cells. Kidney Int 60:1726–1736PubMedCrossRefGoogle Scholar
  25. Li-Ping X, Skrezek C, Wand H, Reibe F (2000) Mitochondrial dysfunction at the early estage of cisplatin-induced acute renal failure in rats. J Zhejiang Univ Sci 1:91–96CrossRefGoogle Scholar
  26. Loeffler M, Kroemer G (2000) The mitochondrion in cell death control: certainties and incognita. Exp Cell Res 256:19–26PubMedCrossRefGoogle Scholar
  27. Lund BO, Miller DM, Woods JS (1993) Studies on Hg (II)- induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol 45:2017–2024PubMedCrossRefGoogle Scholar
  28. Masubuchi Y, Suda C, Horie T (2005) Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. J Hepatol 42:110–116PubMedCrossRefGoogle Scholar
  29. Meyer AJ, Hell Rd (2005) Glutathione homeostasis and redox-regulation by sulfhydryl groups. Photosynth Res 86:435–457PubMedCrossRefGoogle Scholar
  30. Park SA, Park HJ, Lee BI, Ahn YH, Kim SU, Choi KS (2001) Bcl-2 blocks cisplatin-induced apoptosis by suppression of ERK-mediated p53 accumulation in B104 cells. Brain Res Mol Brain Res 93:18–26PubMedCrossRefGoogle Scholar
  31. Park MS, De Leon M, Devarajan P (2002) Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol 13:858–865PubMedCrossRefGoogle Scholar
  32. Pedersen PL, Grenawalt JW, Reynafarje B, Hullihen J, Decker GL, Soper JW, Bustamente E (1978) Preparation and characterization of mitochondria and submitochondrial particles of rat liver-derived tissues. Methods Cell Biol 20:411–481PubMedCrossRefGoogle Scholar
  33. Petit JM, Maftah A, Ratinaud MH, Julien R (1992) 10-N-nonyl acridine orange interacts with cardiolipin and allows the quantification of this phospholipid in isolated mitochondria. Eur J Biochem 209:267–273PubMedCrossRefGoogle Scholar
  34. Petrosillo G, Ruggiero FM, Paradies G (2003) Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria. FASEB J 17:2202–2208PubMedCrossRefGoogle Scholar
  35. Sadzuka Y, Shoji T, Takino Y (1992) Mechanism of the increase in lipid peroxide induced by cisplatin in the kidneys of rats. Toxicol Lett 62:293–300PubMedCrossRefGoogle Scholar
  36. Santos AC, Uyemura SA, Santos NA, Mingatto FE, Curti C (1997) Hg(II)-induced renal cytotoxicity: in vitro and in vivo implications for the bioenergetic and oxidative status of mitochondria. Mol Cell Biochem 177:53–59PubMedCrossRefGoogle Scholar
  37. Scarpa A (1979) Measurements of cation transport with metallochromic indicators. In: Fleisher S, Packer L (eds) Methods in enzimology. Academic, New York, pp 301–352Google Scholar
  38. Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25:192–205PubMedCrossRefGoogle Scholar
  39. Shidoji Y, Hayashi K, Komura S, Ohishi N, Yagi K (1999) Loss of molecular interaction between cytochrome c and cardiolipin due to lipid peroxidation. Biochem Biophys Res Commun 264:343–347PubMedCrossRefGoogle Scholar
  40. Singh G (1989) A possible mechanism of cisplatin–induced nephrotoxicity. Toxicology 58:71–80PubMedCrossRefGoogle Scholar
  41. Somani SM, Husain K, Whitworth C, Trammell GL, Malafa M, Rybak LP (2000) Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system. Pharmacol Toxicol 86:234–241PubMedCrossRefGoogle Scholar
  42. Souid AK, Tacka KA, Galvan KA, Penefsky HS (2003) Immediate effects of anticancer drugs on mitochondrial oxygen consumption. Biochem Pharmacol 66:977–987PubMedCrossRefGoogle Scholar
  43. Sueishi K, Mishima K, Makino K, Itoh Y, Tsuruya K, Hirakata H, Oishi R (2002) Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats. Eur J Pharmacol 451:203–208PubMedCrossRefGoogle Scholar
  44. Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27:502–522PubMedCrossRefGoogle Scholar
  45. Tuma R (2001) The two faces of oxygen. Sci Aging Knowledge Environ 2001:1–5Google Scholar
  46. Ueda N, Kaushal GP, Shah SV (2000) Apoptotic mechanisms in acute renal failure. Am J Med 108:403–415PubMedCrossRefGoogle Scholar
  47. Wang D, Lippard SJ (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4:307–320PubMedCrossRefGoogle Scholar
  48. Wang P, Song JH, Song DK, Ang J, Hao C (2006) Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis. Cell Signal 18:1528–1535PubMedCrossRefGoogle Scholar
  49. Zhang JG, Lindup WE (1994) Cisplatin nephrotoxicity: decreases in mitochondrial protein sulphydryl concentration and calcium uptake by mitochondria from rat renal cortical slices. Biochem Pharmacol 47:1127–1135PubMedCrossRefGoogle Scholar
  50. Zhang JG, Lindup WE (1996) Role of calcium in cisplatin-induced cell toxicity in rat renal cortical slices. Toxicology In Vitro 10:205–209CrossRefPubMedGoogle Scholar
  51. Zhang M, Mileykovskaya E, Dowhan W (2002) Gluing the respiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane. J Biol Chem 277:43553–43556PubMedCrossRefGoogle Scholar
  52. Zheng W, Sean R, Graziano JH (1998) Manganese inhibits mitochondrial aconitase: a mechanism of manganese neurotoxicity. Brain Res 799:334–342PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • N. A. G. Santos
    • 1
  • C. S. Catão
    • 1
  • N. M. Martins
    • 1
  • C. Curti
    • 2
  • M. L. P. Bianchi
    • 1
  • A. C. Santos
    • 1
    Email author
  1. 1.Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão PretoUSPRibeirão PretoBrazil
  2. 2.Departamento de Física e Química, Faculdade de Ciências Farmacêuticas de Ribeirão PretoUSPRibeirão PretoBrazil

Personalised recommendations